The purpose of this guideline is to provide recommendations for the management of patients with malignant pleural mesothelioma mpm an aggressive tumor with a poor prognosis. Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent malignant mesothelioma in this summary for clinicians. Nivolumab Or Nivoluma…
Read moreThe average life expectancy is 12 21 months after diagnosis but prognosis may improve with treatment. Clinical behavior of the malignancy is affected by several factors including the continuous mesothelial surface of the pleural cavity which favors local metastasis via exfoliated cells invasion to underlying tissue and other organs within the pleural cavit…
Read more
Social Plugin